Biolog Device Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Biolog Device.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Electronic earnings growth	37.6%
Revenue growth rate	n/a
Future return on equity	n/a
Analyst coverage	None
Last updated	n/a

Recent future growth updates

No updates

Recent updates

Biolog Device Co., Ltd. (KOSDAQ:208710) Might Not Be As Mispriced As It Looks

Nov 14

It's Down 26% But Biolog Device Co., Ltd. (KOSDAQ:208710) Could Be Riskier Than It Looks

Jul 04

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Biolog Device has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

KOSDAQ:A208710 - Analysts future estimates and past financials data (KRW Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
9/30/2024	148,003	-9,614	-4,802	-149	N/A
6/30/2024	142,348	-8,713	-906	2,736	N/A
3/31/2024	142,807	-5,395	-1,730	2,914	N/A
12/31/2023	123,469	-6,073	3,554	6,346	N/A
9/30/2023	102,239	-9,751	6,840	9,937	N/A
6/30/2023	102,320	-2,683	6,719	9,137	N/A
3/31/2023	104,459	-4,154	5,504	7,639	N/A
12/31/2022	104,283	1,679	2,965	4,846	N/A
9/30/2022	99,085	618	2,902	5,753	N/A
6/30/2022	97,319	-3,937	1,813	4,621	N/A
3/31/2022	87,306	842	-4,341	-1,743	N/A
12/31/2021	83,834	-7,231	-6,029	-3,162	N/A
9/30/2021	83,141	-9,794	-4,386	3,105	N/A
6/30/2021	81,309	-13,456	-11,667	1,685	N/A
3/31/2021	79,067	-20,576	-5,045	12,811	N/A
12/31/2020	91,793	-16,895	-20,096	6,227	N/A
9/30/2020	91,846	-7,597	-28,718	-4,150	N/A
6/30/2020	84,226	-1,808	-14,973	6,570	N/A
3/31/2020	94,403	4,864	-2,693	14,809	N/A
12/31/2019	90,419	6,146	14,193	24,732	N/A
9/30/2019	88,586	8,360	12,976	19,126	N/A
6/30/2019	96,439	6,510	12,805	18,901	N/A
3/31/2019	87,525	5,715	-2,947	836	N/A
12/31/2018	81,464	5,890	-4,495	580	N/A
9/30/2018	78,074	3,410	2,874	10,798	N/A
6/30/2018	72,969	4,691	N/A	7,038	N/A
3/31/2018	75,347	4,758	N/A	7,886	N/A
12/31/2017	70,020	3,459	N/A	8,508	N/A
9/30/2017	75,438	6,725	N/A	6,621	N/A
6/30/2017	71,896	4,578	N/A	3,172	N/A
3/31/2017	67,148	3,932	N/A	7,416	N/A
12/31/2016	68,615	6,505	N/A	1,647	N/A
9/30/2016	58,739	2,776	N/A	6,690	N/A
6/30/2016	56,169	4,858	N/A	8,460	N/A
3/31/2016	51,960	5,427	N/A	3,344	N/A
12/31/2015	44,874	3,544	N/A	13,686	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if A208710's forecast earnings growth is above the savings rate (2.7%).

Earnings vs Market: Insufficient data to determine if A208710's earnings are forecast to grow faster than the KR market

High Growth Earnings: Insufficient data to determine if A208710's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if A208710's revenue is forecast to grow faster than the KR market.

High Growth Revenue: Insufficient data to determine if A208710's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if A208710's Return on Equity is forecast to be high in 3 years time

Biolog Device Future Growth

Future criteria checks 0/6

Key information

Recent future growth updates

Recent updates

Biolog Device Co., Ltd. (KOSDAQ:208710) Might Not Be As Mispriced As It Looks

It's Down 26% But Biolog Device Co., Ltd. (KOSDAQ:208710) Could Be Riskier Than It Looks

Does Biolog Device (KOSDAQ:208710) Have A Healthy Balance Sheet?

Full year 2023 earnings released: ₩130 loss per share (vs ₩45.67 profit in FY 2022)

New minor risk - Shareholder dilution

Biolog Device Co., Ltd. announced that it expects to receive KRW 14.999999047 billion in funding

New minor risk - Share price stability

Full year 2022 earnings released: EPS: ₩67.97 (vs ₩190 loss in FY 2021)

Biolog Device Co., Ltd. announced that it expects to receive KRW 10 billion in funding

Biolog Device Co., Ltd. announced that it has received KRW 6.5 billion in funding from Sangsangin Savings Bank, Investment Arm, Sangsangin Plus Savings Bank, Investment Arm

Biolog Device Co., Ltd. announced that it expects to receive KRW 6.5 billion in funding from Sangsangin Savings Bank, Investment Arm, Sangsangin Plus Savings Bank, Investment Arm

Biolog Device Co., Ltd. announced that it expects to receive KRW 6.5 billion in funding from Sangsangin Savings Bank, Investment Arm, Sangsangin Plus Savings Bank, Investment Arm

Investor sentiment deteriorated over the past week

Mosaic Ventures, Luck & Trust Co., Ltd., Han International Co., Ltd., Hannam World and Medi Forum Co.,Ltd. completed the acquisition of 20.9% stake in Kolen Co., Ltd (KOSDAQ:A078650) from Biolog Device Co., Ltd. (KOSDAQ:A208710).

Unibada, Han International, Hannam World and Medi Forum Co.,Ltd. signed an agreement to acquire 20.9% stake in Kolen Co., Ltd (KOSDAQ:A078650) from Biolog Device Co., Ltd. (KOSDAQ:A208710) for KRW 15.5 billion.

Biolog Device Co., Ltd. announced that it has received KRW 15 billion in funding from Sangsangin Savings Bank, Investment Arm, Sangsangin Plus Savings Bank, Investment Arm

Biolog Device Co., Ltd. announced that it expects to receive KRW 15 billion in funding from Sangsangin Savings Bank, Investment Arm, Sangsangin Plus Savings Bank, Investment Arm

We Think Biolog Device (KOSDAQ:208710) Has A Fair Chunk Of Debt

New 90-day high: ₩1,800

Biolog Device (KOSDAQ:208710) Has A Somewhat Strained Balance Sheet

New 90-day low - ₩1,480

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings per Share Growth Forecasts

Future Return on Equity

Discover growth companies